Literature DB >> 4118763

Combination cancer therapy: Presidential address.

E Frei.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4118763

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  29 in total

Review 1.  Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements.

Authors:  Shivanni Kummar; Helen X Chen; John Wright; Susan Holbeck; Myrtle Davis Millin; Joseph Tomaszewski; James Zweibel; Jerry Collins; James H Doroshow
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

Review 2.  DNA repair and personalized breast cancer therapy.

Authors:  Shu-Xia Li; Ashley Sjolund; Lyndsay Harris; Joann B Sweasy
Journal:  Environ Mol Mutagen       Date:  2010 Oct-Dec       Impact factor: 3.216

3.  The effect of ara-C on survival and proliferation of HeLa cells. A time-lapse cinematographic and light microscopic study.

Authors:  A M Lengsfeld; B Maurer-Schultze
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

Review 4.  Chemotherapy in colorectal cancer.

Authors:  T J McElwain
Journal:  Proc R Soc Med       Date:  1973-12

5.  Combination chemotherapy.

Authors:  E Frei
Journal:  Proc R Soc Med       Date:  1974-06

6.  Evolution of a practical policy for chemotherapy of carcinoma of the breast.

Authors:  M L Sutton
Journal:  Proc R Soc Med       Date:  1973-12

7.  Chemotherapy for carcinoma of the bronchus--a brief review.

Authors:  N M Bleehen
Journal:  Postgrad Med J       Date:  1973-10       Impact factor: 2.401

8.  Cancer Chemoprevention: Preclinical In Vivo Alternate Dosing Strategies to Reduce Drug Toxicities.

Authors:  Altaf Mohammed; Jennifer T Fox; Mark Steven Miller
Journal:  Toxicol Sci       Date:  2019-08-01       Impact factor: 4.849

Review 9.  Combination chemoprevention for colon cancer targeting polyamine synthesis and inflammation.

Authors:  Eugene W Gerner; Frank L Meyskens
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

10.  Antineoplastic activity of idazoxan hydrochloride.

Authors:  G F Eilon; L Weisenthal; M Stupecky; G Landucci; L M Slater
Journal:  Cancer Chemother Pharmacol       Date:  2009-03-24       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.